These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19483707)

  • 1. Prasugrel.
    Huber K; Yasothan U; Hamad B; Kirkpatrick P
    Nat Rev Drug Discov; 2009 Jun; 8(6):449-50. PubMed ID: 19483707
    [No Abstract]   [Full Text] [Related]  

  • 2. Ischaemia versus bleeding: the art of clinical decision-making.
    Stone GW
    Lancet; 2009 Feb; 373(9665):695-6. PubMed ID: 19249613
    [No Abstract]   [Full Text] [Related]  

  • 3. Another view on prasugrel.
    Calatzis A
    Thromb Haemost; 2009 Jan; 101(1):12-3. PubMed ID: 19132183
    [No Abstract]   [Full Text] [Related]  

  • 4. Intensive antiplatelet therapy for reduction of ischaemic events.
    Ramaraj R
    Lancet; 2008 Aug; 372(9638):531; author reply 532. PubMed ID: 18707975
    [No Abstract]   [Full Text] [Related]  

  • 5. Prasugrel and cancer.
    Cattaneo M
    Arch Intern Med; 2010 Nov; 170(21):1944. PubMed ID: 21098359
    [No Abstract]   [Full Text] [Related]  

  • 6. Prasugrel, a third generation thienopyridine and potent platelet inhibitor.
    Gurbel PA; Tantry US
    Curr Opin Investig Drugs; 2008 Mar; 9(3):324-36. PubMed ID: 18311669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will prasugrel supersede clopidogrel for acute coronary syndromes?
    Hankey GJ; Eikelboom JW; Langton PE
    Med J Aust; 2008 Apr; 188(7):381-2. PubMed ID: 18393737
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet inhibitors: update on clopidogrel (Plavix) and the recently approved prasugrel (Effient).
    Wynn RL
    Gen Dent; 2010; 58(1):7-9. PubMed ID: 20129886
    [No Abstract]   [Full Text] [Related]  

  • 9. Clopidogrel versus prasugrel: times are changing, but not for everyone.
    Dobesh PP
    Pharmacotherapy; 2009 Dec; 29(12):1393-6. PubMed ID: 19947798
    [No Abstract]   [Full Text] [Related]  

  • 10. Prasugrel versus clopidogrel in patients with acute coronary syndromes.
    Wiviott SD; Braunwald E; McCabe CH; Montalescot G; Ruzyllo W; Gottlieb S; Neumann FJ; Ardissino D; De Servi S; Murphy SA; Riesmeyer J; Weerakkody G; Gibson CM; Antman EM;
    N Engl J Med; 2007 Nov; 357(20):2001-15. PubMed ID: 17982182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prasugrel: a novel antiplatelet therapy for acute coronary syndromes.
    Singh S; Singh M; Pahwa H; Jawad E; Khosla S; Arora R
    Recent Pat Cardiovasc Drug Discov; 2009 Nov; 4(3):192-202. PubMed ID: 19538177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor--is there need for a new player in the antiplatelet-therapy field?
    Schömig A
    N Engl J Med; 2009 Sep; 361(11):1108-11. PubMed ID: 19717845
    [No Abstract]   [Full Text] [Related]  

  • 13. [Platelet inhibition with prasugrel].
    Gassanov N; Caglayan E; Nia AM; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Aug; 135(31-32):1542-6. PubMed ID: 20665417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaching an age of reason with antiplatelet therapy.
    Ajani AE; Lefkovits J
    Lancet; 2008 Apr; 371(9621):1315-6. PubMed ID: 18424309
    [No Abstract]   [Full Text] [Related]  

  • 15. Prasugrel (Effient) vs. clopidogrel (Plavix).
    Med Lett Drugs Ther; 2009 Sep; 51(1320):69-70. PubMed ID: 19738549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prodrug activation as a crucial difference. Prasugrel - a new ADP receptor antagonist].
    Alban S
    Pharm Unserer Zeit; 2009; 38(4):320-8. PubMed ID: 19572350
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of ticagrelor in clopidogrel nonresponders: resistance is futile?
    Tapp L; Shantsila E; Lip GY
    Circulation; 2010 Mar; 121(10):1169-71. PubMed ID: 20194888
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.
    Testa L; Bhindi R; Van Gaal WJ; Latini RA; Pizzocri S; Lanotte S; Biondi Zoccai GG; Valgimigli M; Laudisa ML; Brambilla N; Banning AP; Bedogni F
    QJM; 2010 Jun; 103(6):367-77. PubMed ID: 20211848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prasugrel hydrochloride, dronedarone, and saxagliptin hydrochloride.
    Hussar DA
    J Am Pharm Assoc (2003); 2009; 49(6):832-6. PubMed ID: 19926567
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and clinical use of prasugrel and ticagrelor.
    Ahmad S; Storey RF
    Curr Pharm Des; 2012; 18(33):5240-60. PubMed ID: 22724412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.